The impact of COVID-19 on chronic pain

被引:0
作者
Lavin, Abraham [1 ]
LeBlanc, Felix [2 ]
El Helou, Antonios [1 ,2 ,3 ]
机构
[1] Univ Sherbrooke, Fac Med, Sherbrooke, PQ, Canada
[2] Horizon Hlth Network, Div Neurosurg, Moncton, NB, Canada
[3] Mem Univ Newfoundland, Fac Med, St John, NF, Canada
来源
FRONTIERS IN PAIN RESEARCH | 2023年 / 4卷
关键词
COVID-19; chronic pain; pathophysiology and mechanism; therapeutic options; pandemic; DYSFUNCTION;
D O I
10.3389/fpain.2023.1234099
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A reduced quality of life is often a hefty burden that those with chronic pain are left to bear. This review of literature from PubMed, Google Scholar and other relevant studies focuses on the complex relationship between COVID-19 and chronic pain, which is challenging to study during the COVID-19 pandemic. In this review, we will briefly discuss the epidemiologic facts and risk factors, followed by the proposed pathophysiologic mechanisms. Furthermore, we will cover the therapeutic avenues regarding various molecules and their possible interactions, with the most promising being those whose mechanism of action can be directly linked to the pathophysiologic aspects of the condition. Finally, we will describe how to deal with a chronic pain patient who consults during the pandemic.
引用
收藏
页数:6
相关论文
共 45 条
  • [1] Covid-19-Induced Dysautonomia: A Menace of Sympathetic Storm
    Al-kuraishy, Hayder M.
    Al-Gareeb, Ali I.
    Qusti, Safaa
    Alshammari, Eida M.
    Gyebi, Gideon Ampoma.
    Batiha, Gaber El-Saber
    [J]. ASN NEURO, 2021, 13
  • [2] Nervous System-Systemic Crosstalk in SARS-CoV-2/COVID-19: A Unique Dyshomeostasis Syndrome
    Anand, Harnadar
    Ende, Victoria
    Singh, Gurinder
    Qureshi, Irfan
    Duong, Tim Q.
    Mehler, Mark F.
    [J]. FRONTIERS IN NEUROSCIENCE, 2021, 15
  • [3] [Anonymous], 2020, Healthcare IT News
  • [4] [Anonymous], 2021, Increasing Transparency Into COVID-19 Spending
  • [5] [Anonymous], COVID 19 FPM RESP SA
  • [6] Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms
    Baig, Abdul Mannan
    Khaleeq, Areeba
    Ali, Usman
    Syeda, Hira
    [J]. ACS CHEMICAL NEUROSCIENCE, 2020, 11 (07): : 995 - 998
  • [7] Center for Drug Evaluation and Research, 2020, FDA ADV PAT US NONST
  • [8] Naltrexone a potential therapeutic candidate for COVID-19
    Choubey, Abhinav
    Dehury, Budheswar
    Kumar, Sunil
    Medhi, Bikash
    Mondal, Prosenjit
    [J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (03) : 963 - 970
  • [9] Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies
    Dani, Melanie
    Dirksen, Andreas
    Taraborrelli, Patricia
    Torocastro, Miriam
    Panagopoulos, Dimitrios
    Sutton, Richard
    Lim, Phang Boon
    [J]. CLINICAL MEDICINE, 2021, 21 (01) : E63 - E67
  • [10] Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists
    Day, Michael
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2020, 368 : m1086